182 related articles for article (PubMed ID: 10541334)
1. Radiolabeling of an anti-carcinoembryonic antigen antibody Fab' fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m.
Griffiths GL; Goldenberg DM; Roesch F; Hansen HJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3001s-3003s. PubMed ID: 10541334
[TBL] [Abstract][Full Text] [Related]
2. Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates.
Ultee ME; Bridger GJ; Abrams MJ; Longley CB; Burton CA; Larsen SK; Henson GW; Padmanabhan S; Gaul FE; Schwartz DA
J Nucl Med; 1997 Jan; 38(1):133-8. PubMed ID: 8998167
[TBL] [Abstract][Full Text] [Related]
3. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeling of affinity-purified goat anti-carcinoembryonic antigen immunoglobulin G with technetium-99m.
Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
Cancer Res; 1980 Aug; 40(8 Pt 2):3043-5. PubMed ID: 7397698
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
[TBL] [Abstract][Full Text] [Related]
7. Early clinical results with anti-CEA F(ab')2 fragments labelled with 99mTc.
Seccamani E; Bonino C; Tarditi L; Camagna M; Moscatelli G; Riva P
J Nucl Med Allied Sci; 1990; 34(4 Suppl):169-72. PubMed ID: 1965448
[No Abstract] [Full Text] [Related]
8. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
[TBL] [Abstract][Full Text] [Related]
9. Detection of invasive Candida albicans infection using a specific (99m)Tc-labeled monoclonal antibody for the C. albicans germ tube.
Ge L; Wang L; Song QH; Yang MF; Sun RM; Zhong BY; Xu Y; Huang DD; Hao F
Appl Microbiol Biotechnol; 2012 Mar; 93(5):2099-108. PubMed ID: 21894481
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
[TBL] [Abstract][Full Text] [Related]
11. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.
Wu AM; Yazaki PJ; Tsai Sw; Nguyen K; Anderson AL; McCarthy DW; Welch MJ; Shively JE; Williams LE; Raubitschek AA; Wong JY; Toyokuni T; Phelps ME; Gambhir SS
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8495-500. PubMed ID: 10880576
[TBL] [Abstract][Full Text] [Related]
12. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
13. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
[TBL] [Abstract][Full Text] [Related]
14. An instant kit method for labeling antimyosin Fab' with technetium-99m: evaluation in an experimental myocardial infarct model.
Pak KY; Nedelman MA; Kanke M; Khaw BA; Mattis JA; Strauss HW; Dean RT; Berger HJ
J Nucl Med; 1992 Jan; 33(1):144-9. PubMed ID: 1730981
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results.
Kramer EL; Noz ME; Liebes L; Murthy S; Tiu S; Goldenberg DM
Cancer; 1994 Feb; 73(3 Suppl):890-5. PubMed ID: 8306275
[TBL] [Abstract][Full Text] [Related]
17. Bacterial expression of a kemptide fusion protein facilitates 32P labeling of a humanized, anti-carcinoembryonic antigen (hMN-14) antibody fragment.
Leung SO; Karacay H; Losman MJ; Griffiths GL; Goldenberg DM; Hansen HJ
Cancer Res; 1995 Dec; 55(23 Suppl):5968s-5972s. PubMed ID: 7493378
[TBL] [Abstract][Full Text] [Related]
18. Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen.
Hong H; Sun J; Cai W
Biomark Insights; 2008 Sep; 3():435-451. PubMed ID: 19578524
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of an "instant" 99mTc-labeling kit for antibody imaging.
Hansen HJ; Jones AL; Sharkey RM; Grebenau R; Blazejewski N; Kunz A; Buckley MJ; Newman ES; Ostella F; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):794s-798s. PubMed ID: 2297726
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
